Dr. Irfan Ahmed Vaziri
Claim this profileNebraska Hematology-Oncology, P.C.
Studies Breast Cancer
1 reported clinical trial
5 drugs studied
Area of expertise
1Breast Cancer
Stage I
Stage II
HER2 negative
Clinical Trials Irfan Ahmed Vaziri is currently running
More about Irfan Ahmed Vaziri
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Irfan Ahmed Vaziri has experience with
- Anastrozole
- Exemestane
- Imlunestrant
- Letrozole
- Tamoxifen
Breakdown of trials Irfan Ahmed Vaziri has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Irfan Ahmed Vaziri specialize in?
Irfan Ahmed Vaziri focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved Stage I patients, or patients who are Stage II.
Is Irfan Ahmed Vaziri currently recruiting for clinical trials?
Yes, Irfan Ahmed Vaziri is currently recruiting for 1 clinical trial in Lincoln Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Irfan Ahmed Vaziri has studied deeply?
Yes, Irfan Ahmed Vaziri has studied treatments such as Anastrozole, Exemestane, Imlunestrant.
What is the best way to schedule an appointment with Irfan Ahmed Vaziri?
Apply for one of the trials that Irfan Ahmed Vaziri is conducting.
What is the office address of Irfan Ahmed Vaziri?
The office of Irfan Ahmed Vaziri is located at: Nebraska Hematology-Oncology, P.C., Lincoln, Nebraska 68506 United States. This is the address for their practice at the Nebraska Hematology-Oncology, P.C..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.